Your browser doesn't support javascript.
loading
The effector program of human CD8 T cells supports tissue remodeling.
Delacher, Michael; Schmidleithner, Lisa; Simon, Malte; Stüve, Philipp; Sanderink, Lieke; Hotz-Wagenblatt, Agnes; Wuttke, Marina; Schambeck, Kathrin; Ruhland, Brigitte; Hofmann, Veronika; Bittner, Sebastian; Ritter, Uwe; Pant, Asmita; Helbich, Sara Salome; Voss, Morten; Lemmermann, Niels A; Bessiri-Schake, Lisa; Bohn, Toszka; Eigenberger, Andreas; Menevse, Ayse Nur; Gebhard, Claudia; Strieder, Nicholas; Abken, Hinrich; Rehli, Michael; Huehn, Jochen; Beckhove, Philipp; Hehlgans, Thomas; Junger, Henrik; Geissler, Edward K; Prantl, Lukas; Werner, Jens M; Schmidl, Christian; Brors, Benedikt; Imbusch, Charles D; Feuerer, Markus.
Affiliation
  • Delacher M; Leibniz Institute for Immunotherapy , Regensburg, Germany.
  • Schmidleithner L; Chair for Immunology, University Regensburg , Regensburg, Germany.
  • Simon M; Institute of Immunology, University Medical Center Mainz , Mainz, Germany.
  • Stüve P; Research Center for Immunotherapy, University Medical Center Mainz , Mainz, Germany.
  • Sanderink L; Leibniz Institute for Immunotherapy , Regensburg, Germany.
  • Hotz-Wagenblatt A; Chair for Immunology, University Regensburg , Regensburg, Germany.
  • Wuttke M; Leibniz Institute for Immunotherapy , Regensburg, Germany.
  • Schambeck K; Faculty of Biosciences, Heidelberg University , Heidelberg, Germany.
  • Ruhland B; Division of Applied Bioinformatics, German Cancer Research Center, Heidelberg, Germany.
  • Hofmann V; Leibniz Institute for Immunotherapy , Regensburg, Germany.
  • Bittner S; Chair for Immunology, University Regensburg , Regensburg, Germany.
  • Ritter U; Leibniz Institute for Immunotherapy , Regensburg, Germany.
  • Pant A; Chair for Immunology, University Regensburg , Regensburg, Germany.
  • Helbich SS; Core Facility Omics IT and Data Management, German Cancer Research Center , Heidelberg, Germany.
  • Voss M; Leibniz Institute for Immunotherapy , Regensburg, Germany.
  • Lemmermann NA; Chair for Immunology, University Regensburg , Regensburg, Germany.
  • Bessiri-Schake L; Leibniz Institute for Immunotherapy , Regensburg, Germany.
  • Bohn T; Chair for Immunology, University Regensburg , Regensburg, Germany.
  • Eigenberger A; Leibniz Institute for Immunotherapy , Regensburg, Germany.
  • Menevse AN; Chair for Immunology, University Regensburg , Regensburg, Germany.
  • Gebhard C; Leibniz Institute for Immunotherapy , Regensburg, Germany.
  • Strieder N; Chair for Immunology, University Regensburg , Regensburg, Germany.
  • Abken H; Leibniz Institute for Immunotherapy , Regensburg, Germany.
  • Rehli M; Chair for Immunology, University Regensburg , Regensburg, Germany.
  • Huehn J; Leibniz Institute for Immunotherapy , Regensburg, Germany.
  • Beckhove P; Chair for Immunology, University Regensburg , Regensburg, Germany.
  • Hehlgans T; Leibniz Institute for Immunotherapy , Regensburg, Germany.
  • Junger H; Chair for Immunology, University Regensburg , Regensburg, Germany.
  • Geissler EK; Institute of Immunology, University Medical Center Mainz , Mainz, Germany.
  • Prantl L; Research Center for Immunotherapy, University Medical Center Mainz , Mainz, Germany.
  • Werner JM; Institute of Immunology, University Medical Center Mainz , Mainz, Germany.
  • Schmidl C; Research Center for Immunotherapy, University Medical Center Mainz , Mainz, Germany.
  • Brors B; Research Center for Immunotherapy, University Medical Center Mainz , Mainz, Germany.
  • Imbusch CD; Institute of Virology, University Medical Center Mainz , Mainz, Germany.
  • Feuerer M; Institute of Virology, University of Bonn , Bonn, Germany.
J Exp Med ; 221(2)2024 Feb 05.
Article in En | MEDLINE | ID: mdl-38226976
ABSTRACT
CD8 T lymphocytes are classically viewed as cytotoxic T cells. Whether human CD8 T cells can, in parallel, induce a tissue regeneration program is poorly understood. Here, antigen-specific assay systems revealed that human CD8 T cells not only mediated cytotoxicity but also promoted tissue remodeling. Activated CD8 T cells could produce the epidermal growth factor receptor (EGFR)-ligand amphiregulin (AREG) and sensitize epithelial cells for enhanced regeneration potential. Blocking the EGFR or the effector cytokines IFN-γ and TNF could inhibit tissue remodeling. This regenerative program enhanced tumor spheroid and stem cell-mediated organoid growth. Using single-cell gene expression analysis, we identified an AREG+, tissue-resident CD8 T cell population in skin and adipose tissue from patients undergoing abdominal wall or abdominoplasty surgery. These tissue-resident CD8 T cells showed a strong TCR clonal relation to blood PD1+TIGIT+ CD8 T cells with tissue remodeling abilities. These findings may help to understand the complex CD8 biology in tumors and could become relevant for the design of therapeutic T cell products.
Subject(s)

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: T-Lymphocytes, Cytotoxic / CD8-Positive T-Lymphocytes Type of study: Prognostic_studies Limits: Humans Language: En Journal: J Exp Med / J. exp. med / Journal of experimental medicine Year: 2024 Document type: Article Affiliation country: Alemania Country of publication: Estados Unidos

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: T-Lymphocytes, Cytotoxic / CD8-Positive T-Lymphocytes Type of study: Prognostic_studies Limits: Humans Language: En Journal: J Exp Med / J. exp. med / Journal of experimental medicine Year: 2024 Document type: Article Affiliation country: Alemania Country of publication: Estados Unidos